Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002297 · ClinicalTrials.gov registry record · NA
A Study of Isoprinosine in Patients With Lymph Node Disease
A NA study of HIV Infections and Lymphatic Disease, sponsored by Newport Pharmaceuticals International.
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00002297 is a NA study of HIV Infections and Lymphatic Disease that has completed, run by Newport Pharmaceuticals International. The trial reports 1 study location across 1 state.
The verdict
NCT00002297, a NA study of HIV Infections and Lymphatic Disease, has completed, sponsored by Newport Pharmaceuticals International.
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
The objectives of this study are to determine the effects of isoprinosine in patients diagnosed as having unexplained generalized lymphadenopathy. Variables to be examined will include: Signs and symptoms: * Lymphadenopathy. * Fever. * Weight loss. * Occurrence of opportunistic infections. Cell-mediated immune system parameters: * T-helper cell (OKT4) numbers and proportions. * T-suppressor cell (OKT8) numbers and proportions. * Natural killer (NK) cell activity. * Lymphocyte blastogenic response to phytohemagglutinin (PHA). * Lymphocyte blastogenic response to pokeweed mitogen (PWM). * Immunoglobulin (IgG, IgA, IgM, IgE, IgD) profile. * Circulating immune complexes. Infections characteristically associated with AIDS, such as Candida albicans, Pneumocystis carinii pneumonia, Cytomegalovirus, Herpes simplex, Cryptococcus, Histoplasma, Toxoplasma, Cryptosporidium, Mycobacterium avium- intracellulare, Legionella, and Isospora. Safety parameters: * Blood chemistry including serum uric acid (PurposeA-12). * Complete blood count (CBC). * Platelet count.
Conditions Studied
Interventions
- DRUG Inosine pranobex
Study Locations (1)
California
- Newport Pharmaceuticals International Inc - Laguna Hills
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002297
The ClinicalTrials.gov registry entry for NCT00002297 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Newport Pharmaceuticals International, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Inosine pranobex is the first listed.
NCT00002297 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00002297 about?
NCT00002297 is a clinical study titled "A Study of Isoprinosine in Patients With Lymph Node Disease". The objectives of this study are to determine the effects of isoprinosine in patients diagnosed as having unexplained generalized lymphadenopathy. Variables to be examined will include: Signs and symptoms: * Lymphadenopathy. * Fever. * Weight loss. * Occurrence of opportunistic infections. Cell-m...
What is the current status of trial NCT00002297?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002297 study?
This clinical trial studies the following conditions: HIV Infections, Lymphatic Disease.
What interventions are being tested in trial NCT00002297?
The interventions under investigation include: Inosine pranobex (DRUG).
Who is sponsoring clinical trial NCT00002297?
This trial is sponsored by Newport Pharmaceuticals International, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002297 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.